Moreover, CCL18 released from neuroprotective microglia, can block the recruitment of T cells in tumors, reduce the suppressive effect of Treg cells, and regulate the immune response by inhibiting the CCL18-PITPNM3 signaling pathway in tumor-related research [102, 126–129]. Here, CCL18 is linked to neoplasm.